H
Hong Ding
Researcher at University of California, Berkeley
Publications - 65
Citations - 9199
Hong Ding is an academic researcher from University of California, Berkeley. The author has contributed to research in topics: Perovskite (structure) & Gene silencing. The author has an hindex of 40, co-authored 65 publications receiving 7925 citations. Previous affiliations of Hong Ding include AbbVie & Lawrence Berkeley National Laboratory.
Papers
More filters
Journal ArticleDOI
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J. Souers,Joel D. Leverson,Erwin R. Boghaert,Scott L. Ackler,Nathaniel D. Catron,Jun Chen,Brian D. Dayton,Hong Ding,Sari H. Enschede,Wayne J. Fairbrother,David C.S. Huang,David C.S. Huang,Sarah G. Hymowitz,Sha Jin,Seong Lin Khaw,Seong Lin Khaw,Peter Kovar,Lloyd T. Lam,Jackie Lee,Heather Maecker,Kennan C. Marsh,Kylie D. Mason,Kylie D. Mason,Kylie D. Mason,Michael J. Mitten,Paul Nimmer,Anatol Oleksijew,Chang H. Park,Cheol-Min Park,Cheol-Min Park,Darren C. Phillips,Andrew W. Roberts,Andrew W. Roberts,Andrew W. Roberts,Deepak Sampath,John F. Seymour,John F. Seymour,Morey L. Smith,Gerard M. Sullivan,Stephen K. Tahir,Chris Tse,Michael D. Wendt,Yu Xiao,John Xue,Haichao Zhang,Rod A. Humerickhouse,Saul H. Rosenberg,Steven W. Elmore +47 more
TL;DR: The re-engineering of navitoclax is reported to create a highly potent, orally bioavailable and BCL-2–selective inhibitor, ABT-199, which inhibits the growth of BCL–dependent tumors in vivo and spares human platelets, indicating that selective pharmacological inhibition of Bcl-2 shows promise for the treatment of B CL-2-dependent hematological cancers.
Journal ArticleDOI
Lead‐Free Halide Perovskite Solar Cells with High Photocurrents Realized Through Vacancy Modulation
Mulmudi Hemant Kumar,Sabba Dharani,Wei Lin Leong,Pablo P. Boix,Rajiv Ramanujam Prabhakar,Tom Baikie,Chen Shi,Hong Ding,Ramamoorthy Ramesh,Mark Asta,Michael Graetzel,Michael Graetzel,Subodh Mhaisalkar,Nripan Mathews +13 more
TL;DR: Lead free perovskite solar cells based on a CsSnI3 light absorber with a spectral response from 950 nm with high photocurrents are demonstrated.
Journal ArticleDOI
Lead-free germanium iodide perovskite materials for photovoltaic applications
Thirumal Krishnamoorthy,Hong Ding,Chen Yan,Wei Lin Leong,Tom Baikie,Ziyi Zhang,Matthew Sherburne,Shuzhou Li,Mark Asta,Nripan Mathews,Nripan Mathews,Subodh Mhaisalkar +11 more
TL;DR: In this paper, a computational screening based on density-functional-theory calculations reveals Ge as a candidate element for replacing Pb in halide perovskite compounds suitable for light harvesting.
Journal ArticleDOI
In vivo targeted cancer imaging, sentinel lymph node mapping and multi-channel imaging with biocompatible silicon nanocrystals.
Folarin Erogbogbo,Ken-Tye Yong,Indrajit Roy,Rui Hu,Wing Cheung Law,Wei-Wei Zhao,Hong Ding,Fang Wu,Rajiv Kumar,Mark T. Swihart,Paras N. Prasad +10 more
TL;DR: This work overcomes dispersibility and functionalization challenges to in vivo imaging with Si QDs through a unique nanoparticle synthesis, surface functionalization, PEGylated micelle encapsulation, and bioconjugation process that produces bright, targeted nanospheres with stable luminescence and long tumor accumulation time in vivo.
Journal ArticleDOI
Imaging pancreatic cancer using bioconjugated InP quantum dots.
Ken-Tye Yong,Hong Ding,Indrajit Roy,Wing Cheung Law,Earl J. Bergey,Anirban Maitra,Paras N. Prasad +6 more
TL;DR: The successful use of non-cadmium-based quantum dots (QDs) as highly efficient and nontoxic optical probes for imaging live pancreatic cancer cells and the immense potential of InP/ZnS QDs in diagnostic imaging, particularly for early detection of cancer is suggested.